- 期刊
全球前2%頂尖科學家的台灣醫界學者：排名增進率與作者論文紀要的視覺圖
Taiwanese Medical Scholars among the Global Top 2% Scientists: Ranking Advancement Rate and Visual Summary of Author Publications
摘要
2024年「全球前2%頂尖科學家」的發布，引起醫界學者的重視。傳統上，係以國際排名前後的台灣學者為介紹標的，未見其以排名邁進的大小為依據。台北市立關渡醫院院長陳亮恭再度蟬聯國內第一，已是該榜單發表以來，連續五年皆列全國第一，其排名邁進是否仍屬超前，卻不明確。本研究驗證此假設：陳醫師的排名邁進，在台灣醫界仍屬超前，並以視覺圖論文的屬性及其熱點趨勢。研究資料下載2022及2024年「全球前2%頂尖科學家」的名冊資料，以其關鍵10項被引用量的指標，納入基因表達分析（|log2FC|>1.0及-𝑙𝑜𝑔10（𝑎𝑑𝑗. 𝑃. 𝑉𝑎𝑙𝑢𝑒 < 0.05）為閾值，挑出被引用量顯著成長的台灣學者，檢視陳醫師是否仍在列。排名增進率為取對數的2022年排名，除以2024年排名（即ln（2022年排名／2024年排名），正值表示排名進步，負值表示退步）。研究結果顯示：醫界53領域中，2022及2024年皆列入的學者計36,873人，台灣學者184人，其中屬醫院部門科系者99人。去除外籍於台灣任教的學者，只兩位醫師列入顯著排名邁進的名冊，陳醫師邁進排名仍屬第一，因此可以預測2025年陳醫師在台灣學者的排名，仍會是第一（概其排名增進率=3.33）。利用3幅視覺圖，即論文紀要、熱點趨勢、及論文儀表板，呈現陳醫師的著作屬性與亮點，對傳統網頁論文列表，提供輔助的功能。陳醫師於台灣學者排名第一，且其排名增進率也列第一。史丹佛大學的專家們，透過Scopus的學者檔案，發布「全球前2%頂尖科學家」的排名發布，宜再列入排名增進率，以為預測次年排名邁進的依據與參考。
並列摘要
The release of the 2024 "Global Top 2% Scientists" list has drawn significant attention among medical scholars, especially regarding the ranking of Taiwanese researchers. Dr. Liang-Kung Chen, Director of Taipei City Gan-Dau Hospital, has maintained the top domestic position for the fifth consecutive year. This study investigates whether Dr. Chen's ranking advancement remains ahead within the Taiwanese medical community and visually analyzes his publications. Data were collected from the 2022 and 2024 editions of the list. Gene expression analysis with citation growth indicators was used to identify significant advancements among Taiwanese scholars. The ranking advancement rate was calculated, with positive values indicating progress. Among 53 medical fields, 36,873 scholars were listed in both years, including 184 Taiwanese scholars, of whom 99 were affiliated with hospital departments. After excluding foreign scholars, only two physicians showed significant ranking advancement, with Dr. Chen still leading. It is predicted that he will continue to hold the top rank in 2025 (advancement rate = 3.33). Three visual charts-a summary of publications, a trend hotspot map, and a publication dashboard-were used to present Dr. Chen's research highlights, supplementing traditional listing formats. Dr. Chen remains the leading Taiwanese scholar, and it is recommended that future releases of the "Global Top 2% Scientists" using Scopus scholar profiles include ranking advancement rates as a reference for predicting ranking progress.